Latest Insider Transactions at Outset Medical, Inc. (OM)
This section provides a real-time view of insider transactions for Outset Medical, Inc. (OM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Outset Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Outset Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-19.26%
|
$150,500
$43.83 P/Share
|
|
Jul 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
Jul 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
42,500
-4.06%
|
$2,082,500
$49.25 P/Share
|
|
Jul 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+3.89%
|
$85,000
$2.48 P/Share
|
|
Jul 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-28.27%
|
$63,504
$49.23 P/Share
|
|
Jul 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+22.04%
|
$1,296
$1.11 P/Share
|
|
Jul 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,000
-36.49%
|
$784,000
$49.25 P/Share
|
|
Jul 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+26.72%
|
$48,000
$3.88 P/Share
|
|
Jun 24
2021
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,727
-55.16%
|
$836,350
$50.72 P/Share
|
|
Jun 24
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,727
+35.55%
|
$100,362
$6.25 P/Share
|
|
Jun 22
2021
|
Jean Olivier Racine Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,879
+50.0%
|
-
|
|
Jun 17
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,445
-8.97%
|
$72,250
$50.0 P/Share
|
|
Jun 17
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,445
+8.23%
|
$13,005
$9.48 P/Share
|
|
Jun 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-19.26%
|
$164,500
$47.87 P/Share
|
|
Jun 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
Jun 03
2021
|
Andrea Lynn Saia Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+28.3%
|
-
|
|
Jun 03
2021
|
D Keith Grossman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+50.0%
|
-
|
|
Jun 03
2021
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+24.68%
|
-
|
|
Jun 03
2021
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+27.49%
|
-
|
|
Jun 03
2021
|
Patrick T Hackett Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+50.0%
|
-
|
|
Jun 03
2021
|
James F. Hinrichs Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,288
+12.37%
|
-
|
|
Jun 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-7.39%
|
$940,000
$47.9 P/Share
|
|
Jun 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.88%
|
$20,000
$1.11 P/Share
|
|
Jun 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-35.08%
|
$235,000
$47.91 P/Share
|
|
Jun 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.97%
|
$15,000
$3.88 P/Share
|
|
Jun 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-100.0%
|
$60,912
$47.92 P/Share
|
|
Jun 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+50.0%
|
$1,296
$1.11 P/Share
|
|
May 25
2021
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,727
-55.16%
|
$752,715
$45.11 P/Share
|
|
May 25
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,727
+35.55%
|
$100,362
$6.25 P/Share
|
|
May 20
2021
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,747
+46.0%
|
-
|
|
May 17
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-19.26%
|
$147,000
$42.34 P/Share
|
|
May 17
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
May 03
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
2,592
-73.06%
|
$150,336
$58.72 P/Share
|
|
May 03
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,592
+50.0%
|
$2,592
$1.11 P/Share
|
|
May 03
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-12.5%
|
$290,000
$58.84 P/Share
|
|
May 03
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.03%
|
$15,000
$3.88 P/Share
|
|
May 03
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-2.5%
|
$1,160,000
$58.79 P/Share
|
|
May 03
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.88%
|
$20,000
$1.11 P/Share
|
|
Apr 27
2021
|
Rebecca Chambers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,727
-32.86%
|
$936,712
$56.61 P/Share
|
|
Apr 27
2021
|
Rebecca Chambers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,727
+35.55%
|
$100,362
$6.25 P/Share
|
|
Apr 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-9.75%
|
$189,000
$54.55 P/Share
|
|
Apr 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.15%
|
$31,500
$9.48 P/Share
|
|
Apr 13
2021
|
Warburg Pincus X, L.P. |
SELL
Open market or private sale
|
Indirect |
3,890,723
-82.22%
|
$194,536,150
$50.83 P/Share
|
|
Apr 13
2021
|
Warburg Pincus LLC |
SELL
Open market or private sale
|
Indirect |
3,890,723
-82.22%
|
$194,536,150
$50.83 P/Share
|
|
Apr 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
2,592
-100.0%
|
$142,560
$55.06 P/Share
|
|
Apr 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,592
+50.0%
|
$2,592
$1.11 P/Share
|
|
Apr 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
57,500
-9.81%
|
$3,162,500
$55.37 P/Share
|
|
Apr 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
57,500
+6.2%
|
$57,500
$1.11 P/Share
|
|
Apr 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
22,500
-42.13%
|
$1,237,500
$55.18 P/Share
|
|
Apr 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+30.11%
|
$67,500
$3.88 P/Share
|